Related Experiment Video
Updated: Jul 3, 2026

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation
Published on: May 3, 2024
Intracellular death platform steps-in: targeting prostate tumors via endoplasmic reticulum (ER) apoptosis
Steven R Schwarze1, Eric W Lin, Perry A Christian
1Department of Molecular/Cellular Biochemistry, University of Kentucky College of Medicine, Lexington, Kentucky 40536, USA.
Abstract:
Molecular targeting of apoptotic signaling pathways has been extensively studied in recent years and directed towards the development of effective therapeutic modalities for treating advanced androgen-independent prostate tumors. The majority of therapeutic agents act through intrinsic or mitochondrial pathways to induce programmed cell death. The induction of apoptosis through endoplasmic reticulum (ER) stress pathways may provide an alternative to treat patients. The functional interaction between the BCL-2 family members and regulation of calcium homeostasis in the ER provides a critical link to the life or death outcome of the cell. Apoptosis induction mediated by ER stress-inducing agents is just beginning to be exploited for therapeutic targeting of prostate tumors. Insightful dissection of recently discovered apoptotic signaling pathways that function through the endoplasmic reticulum may identify novel molecules that could effectively target both androgen-dependent and androgen-independent prostate tumors. In this review, we focus on linking ER stress-induced apoptosis to therapeutic targeting of prostate tumors and dissect its cross-talk with the intrinsic and extrinsic apoptotic pathways.
Insights
Targeting endoplasmic reticulum (ER) stress-induced apoptosis offers a novel therapeutic strategy for prostate tumors. This approach complements existing treatments by exploring ER stress pathways and their interaction with cell death signaling.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Molecular targeting of apoptosis is crucial for treating advanced prostate tumors.
- Current therapies primarily target intrinsic/mitochondrial apoptotic pathways.
- Endoplasmic reticulum (ER) stress pathways present an alternative route for inducing apoptosis.
Purpose of the Study:
- To review the therapeutic potential of ER stress-induced apoptosis in prostate cancer.
- To explore the interplay between ER stress, BCL-2 family proteins, and calcium homeostasis.
- To identify novel therapeutic targets for both androgen-dependent and -independent prostate tumors.
Main Methods:
- Literature review focusing on ER stress-induced apoptosis.
- Analysis of signaling cross-talk between ER stress, intrinsic, and extrinsic apoptotic pathways.
- Examination of the role of BCL-2 family members and ER calcium regulation.
Main Results:
- ER stress-induced apoptosis is an emerging therapeutic strategy for prostate cancer.
- The BCL-2 family and ER calcium homeostasis are critical regulators of cell fate.
- Understanding these pathways can reveal novel therapeutic targets.
Conclusions:
- Targeting ER stress-induced apoptosis offers a promising alternative for prostate tumor treatment.
- Further research into ER stress signaling pathways may yield new therapeutic agents.
- This approach holds potential for both androgen-dependent and -independent prostate cancers.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Intrinsic Apoptotic Pathway
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy
